Avacta Share Price (AVCT)

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta Group Plc LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  0.50 0.42% 119.50 3,063,489 16:25:09
Bid Price Offer Price High Price Low Price Open Price
119.00 120.00 127.00 113.50 118.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 5.51 -18.05 -12.98 297
Last Trade Time Trade Type Trade Size Trade Price Currency
17:18:54 O 20,000 119.75 GBX
Related Shares
Astrazeneca (AZN), Glaxosmithkline (GSK), Bermele (BERM), Valirx (VAL)

Avacta (AVCT) Latest News

Avacta News

Date Time Source Headline
07/7/202014:06UKREGAvacta Group PLC Issue of Equity
03/7/202016:41UKREGAvacta Group PLC Second Price Monitoring Extn
03/7/202016:35UKREGAvacta Group PLC Price Monitoring Extension
24/6/202013:55ALNCIN BRIEF: Avacta Posts Positive Results For Covid-19 Detection Test
24/6/202011:15UKREGAvacta Group PLC Result of General Meeting
24/6/202008:49BWAvacta Provides Update on COVID-19 Rapid Antigen Test Development..
24/6/202007:40ALNCFAlliance News Flash Headline
24/6/202007:00UKREGAvacta Group PLC Update on COVID-19 Test Development Partnership
22/6/202014:52UKREGAvacta Group PLC Result of AGM
18/6/202011:15ALNCAvacta Shares Surge As It Lauds Affimer As Potential Covid-19 Therapy
More Avacta News
Avacta Takeover Rumours

Avacta (AVCT) Discussions and Chat

Avacta Forums and Chat

Date Time Title Posts
10/7/202018:16Covid-19. Ten Minute Test. Gamechanger!!14,272
10/7/202016:40Avacta – Innovative and Disruptive Technologies for Global Health Markets8,558
07/7/202010:20Avacta. 398
06/7/202014:53Avacta – Unique and innovative technology blipping on big pharma’s radar1,836
06/7/202014:37Ten Minutes to Save the World.11

Add a New Thread

Avacta (AVCT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:28:10119.7520,00023,950.00O
16:26:17119.6811,69213,992.99O
16:20:58119.506,7468,061.47O
16:15:00122.5052,10763,831.08O
16:15:00122.4535,11542,998.32O
View all Avacta trades in real-time

Avacta (AVCT) Top Chat Posts

DateSubject
10/7/2020
09:20		Avacta Daily Update: Avacta Group Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 119p.
Avacta Group Plc has a 4 week average price of 95.50p and a 12 week average price of 53p.
The 1 year high share price is 215p while the 1 year low share price is currently 13.50p.
There are currently 248,797,815 shares in issue and the average daily traded volume is 3,151,909 shares. The market capitalisation of Avacta Group Plc is £297,313,388.93.
Read Full Thread
Reply
05/7/2020
18:34		chickndinner: I'm not sure how the market will react tomorrow with this latest news re Boohoo? I'm not invested. I wish I had in the early days as when our youngest daughter was still living at home she was getting deliveries every other day from Pretty Little Thing and other Boohoo companies. Missed the boat on that one! I'm sure there will be a knock on effect tomorrow but I think it will be an opportunity to buy in on the dip. The art will be working out where the bottom is before taking advantage as I'm sure the next financial accounts are going to be very healthy as everyone young women has been buying online for since the lockdown filling up thier wardrobes. If Boohoo do get prosecuted the million dollar question is if they lose their case how much will they have to pay in court costs, fines etc? I think the profits will far outweigh any litigation. My opinion only? Also. I do not believe that this should have any negative impact on the AVCT share price as they are separate enterprises. If it does then it will be totally unjustified. It's now down to AS to prove himself and justify this fund raise and product. That's it. Stay safe x
Read Full Thread
Follow
Reply
02/7/2020
11:19		ambyth: For info for all Long AVCT shareholders: Myles McNulty has posted on one of the other ADVFN AVCT boards this morning: "aim chaos 2 Jul '20 - 10:14 - 389 of 391 0 5 0 Noise around this stock has removed dramatically this week - a sign that short-term traders have left the building. A good thing, in my view. The news pipeline gets more pregnant by the day, and the company's prospects continue to improve. I'm very confident that the share price will smash through the all time high this month. I think the real share price catalyst will be the first pre-order receipt for the LFT. Then it's blue skies ahead. A major coming in the co-develop a COVID-19 NAf therapy would also catalyse a massive, immediate-term rerating, I would think. It's a flip of the coin though, so fingers crossed!"
Read Full Thread
Follow
Reply
02/7/2020
10:14		aim chaos: Noise around this stock has removed dramatically this week - a sign that short-term traders have left the building. A good thing, in my view. The news pipeline gets more pregnant by the day, and the company's prospects continue to improve. I'm very confident that the share price will smash through the all time high this month. I think the real share price catalyst will be the first pre-order receipt for the LFT. Then it's blue skies ahead. A major coming in the co-develop a COVID-19 NAf therapy would also catalyse a massive, immediate-term rerating, I would think. It's a flip of the coin though, so fingers crossed!
Read Full Thread
Follow
Reply
30/6/2020
16:40		ambyth: RichKen has posted the following on the LSE board in the past few minutes which I think is worth reading if you are a Long AVCT shareholder: "AVCT Potential: Just to answer the thread title! Well, it is no secret to anyone on this board that I am positive about the future of Avacta and from any discussions on this board as well as the attention to detail from the Avacta management to present and deliver on goals in a timely and clear way, which for a Biotech company is no mean feat. The detailed expatiations found on the Avacta website as per my post below are so worthy of time. The question that every investor wants to know is what does this mean to the companies market capitalisation and to investors the share price or as the subject ‘the potential’. I think you will find some detailed guidance as an opinion from Myles (Aim Chaos), in his series of papers put together. But if you would like a simple estimation of thoughts over the months ahead based on news, delivery of BAMS, POC, Stage 1 SARS-COV2 Neutraliser, Stage 1 AVA6000 clinical trials and beyond here goes. These are potential share price estimations and there are many factors which may affect these so please do not hold me to them! 1. Succesful BAMS clinical testing and first partnership with sales - Share price moving into the £2 to £3 range 2. Partnership to develop the SARS-COV-2 Blocker - £2.50 to £3.50 3. Succesful approval for the Point of Care LFD with a minimum of two production partnerships and a number of large orders - £4 to £5 4. Increased sales of POC test and numbers growing exponentially around the world £5 to £8 5. Confirmation of first clinical trials for AVA6000 £5 to £8 6. Successful clinical trials for AVA6000 / SARS-COV-2 and moving to stage 2 and stage 3 clinical trials - £10 to £15 Beyond this and within 18 to 24 months with continued progress a share price in excess of £20. I am sure many will make many comments on this and they are all welcome but these amy thoughts. Cheers, Rich"
Read Full Thread
Follow
Reply
17/6/2020
23:33		1jwp: I’ve been trying to work out why AS was not there as Sona had their CEO/Chairman. I don’t think that AS would have let David Wilson Loose if he didn’t have more important things to do like prepare an RNS for tomorrow or he thinks it’s inconsequential to the share price. Does anyone know how long David Wilson has been scheduled to take part in this event? I can’t help feel sequoia have been made aware of something in the pipe that we don’t know about yet as Avacta would know share price is heavily news driven and wouldn’t want to look stupid in front of them with share price going below 120. Also McNulty mentions another test that we are unaware of.
Read Full Thread
Follow
Reply
16/6/2020
14:38		dorset64: I see this fall, and a huge fall its been as almost a perfect storm scenario. The share price rose on expectation of what we have, and we still have it, and an early approval with multi-deals following. Whats actually happened is that the virus is subsiding here in the UK & Europe, where most investors are from, especially private investors. Furthermore they have raised money at a sizeable discount to the then share price and invariably the share price always falls back to the placing price. Then we have the 2 No. presentations last week which did install further hope in investors, and myself that the approval was to be announced, or at the very least news of such prior to the presentations, as what was the point in holding them if theres nothing new to shout about. Added to that the markets have most recently seen a sell off with all or most sectors being affected, which again is perfectly natural given the run back up such sectors have had. Ultimately I sold out my profit from my original investments here but have kept a sizeable amount left in, albeit pretty close to a free run as I do expect AVCT to get approval, I do expect AVCT to sell millions of the test kits and if we look around the world, Covid 19 is not going away any time soon and, right here today it is infecting more people than ever before on a daily basis now that it is reaching the remaining 'BRICS' countries, including Africa. So for me, glad I took a bit of profit but am still more than happy to keep my investment but perhaps if I was a trader or better at this, I would have sold the lot higher up & bought 3 x as many back today. Good luck all, which ever side of the fence you sit.
Read Full Thread
Follow
Reply
15/6/2020
08:47		thefartingcommie: re....Would welcome Stigologist's and other people's opinions on the chart action. from lse.. ..the technicals across all time frames look horrible...major h+s shoulders reversal in play...completes at c 88p. ...there are many instances where ,after a placing,the current share price has fallen considerably below the placing price. Do please correct this statement if you consider it to be ill-informed. So..to regard a share price to be 'good value',and the placing price..'a floor'....could prove to be expensive.
Read Full Thread
Follow
Reply
25/5/2020
19:10		chickndinner: Fictitious1. Yes. Great call. Let's get back to the reason this page was set up for. AVCT. GAME CHANGER... Going to be a Massive news rich week/s from tomorrow onwards. Multi billion £company in the making. I would not be surprised at a 7am RNS. One of many we are awaiting: A couple to ponder on; AVCT are pleased to announce that we have now completed a contract with Amazon exclusive rights to distribute our Saliva based COVID-19 tests to commercial businesses. We are pleased to announce that GSK have made a proposal to buy out AVCT for £100 billion. Share price opening price £25 +
Read Full Thread
Follow
Reply
21/5/2020
15:07		the stigologist: Are you related to Priti Patel ? She thinks the AVCT share price is going to 300,034,974,000 htTps://twitter.com/Stockonomist/status/1263470439944335360?s=20
Read Full Thread
Follow
Reply
19/5/2020
23:59		chickndinner: RIZ000. SORRY TO BLOW MY OWN TRUMPET. I HAVE BEEN A LONG TERM HOLDER IN GGP SINCE BELOW 2P. GGP IS BY FAR MY LARGEST STOCK I HOLD. I RETIRED 2 YEARS AGO AT THE AGE OF 47 TRADING GGP AND SSX BEING PROBABLY THE BEST 2. I HAVE A FREE CARRY IN AVCT. THATS ALL YOU NEED TO KNOW AND I HAVE NO INTENTIONS OF SELLING ANY OF THESE SHARES UNTIL AT LEAST £6 PER SHARE. SORRY IF I SOUND LIKE I AM RAMPING BUT MANY BAGS IN A SHORT PERIOD OF TIME WITH AVCT? I AM WAITING FOR THE 7AM RNS EITHER SAYING THEY HAVE PARTNERED WITH ONE OF THE BIG PHARMA'S OR BEEN BOUGHT OUT! YOU CAN SEE HOW THE MM'S ARE WORKING. LOOK AT THE CHARTS AND BROKER NOTES FOR EXAMPLE WITH GGP? 1st broker note from them was 6p per share but the MM's kept it below 3p. Share price now 9p. Don't let them shake you to soon. Once there is an RNS saying AVCT have an announced a partnership with a big pharma which is on the cusp day traders wont mind so much because that is their strategy. It's not difficult to make money on AIM if you do a lot of research. You either go in gambling as a day trader. Buy on a spike and get locked in if you read a 7am rns and listen to all the hype! Or you buy on rumour and sell on news? I know. It's a load of BS. If you have done your own research and you believe then go for it. If you read these boards and believe what everyone is saying then you should steer well clear! Stay safe
Read Full Thread
Follow
Reply
Avacta share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
AVCT
Avacta
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200710 17:38:34